UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028590
Receipt number R000032692
Scientific Title Safety and Efficacy of Quartz Head Laser Ablation for the Prostate Using 980-nm Laser in Patients With Ongoing Platelet Aggregation Inhibition and Oral Anticoagulation
Date of disclosure of the study information 2017/08/10
Last modified on 2019/02/15 21:16:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety and Efficacy of Quartz Head Laser Ablation for the Prostate Using 980-nm Laser in Patients With Ongoing Platelet Aggregation Inhibition and Oral Anticoagulation

Acronym

Safety and Efficacy of Quartz Head Laser Ablation for the prostate Using 980-nm Laser

Scientific Title

Safety and Efficacy of Quartz Head Laser Ablation for the Prostate Using 980-nm Laser in Patients With Ongoing Platelet Aggregation Inhibition and Oral Anticoagulation

Scientific Title:Acronym

Safety and Efficacy of Quartz Head Laser Ablation for the prostate Using 980-nm Laser

Region

Japan


Condition

Condition

benign prostatic hypertrophy

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the improvement in voiding symptom and the postoperative bleeding-related complication rate between those on anticoagulation versus those who were not undergoing Quartz Head Laser Ablation for the Prostate Using 980-nm diode Laser.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The rate of postoperative hematuria leading to urethral catheter obstruction.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1. >50 years old
2. prostate volume >30cc
3. Meet the criteria for the surgery according to "Clinical Guidelines for Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia" 2017

Key exclusion criteria

1. Individual may not complete 12 months follow up
2. Unable to provide informed consent

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshiaki Shinojima

Organization

Keio University School of Medicine

Division name

Department of Urology

Zip code


Address

35 Shinanomachi, Shinjyuku-ku Tokyo, 160-8582

TEL

03-5363-3825

Email

t-shinoj@cd5.so-net.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Toshiaki Shinojima

Organization

Keio University School of Medicine

Division name

Department of Urology

Zip code


Address

35 Shinanomachi, Shinjyuku-ku Tokyo, 160-8582

TEL

03-5363-3825

Homepage URL


Email

t-shinoj@cd5.so-net.ne.jp


Sponsor or person

Institute

Department of Urology, Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Integral Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 09 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

In this study, the improvement in voiding symptom and the postoperative bleeding-related complication rate would be evaluated in patients receiving Quartz Head Laser Ablation for the Prostate Using 980-nm diode Laser. The results would be compared between those on anticoagulation versus those who were not.


Management information

Registered date

2017 Year 08 Month 08 Day

Last modified on

2019 Year 02 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032692


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name